Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data

Michele Schiavon, Chiara Dalla Man, Simmi Dube, Michael Slama, Yogish C Kudva, Thomas Peyser, Ananda Basu, Rita Basu, Claudio Cobelli

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Quantitative assessment of the dynamic relationship between plasma and interstitial fluid (ISF) glucose and the estimation of the plasma-to-ISF delay are of major importance to determine the accuracy of subcutaneous glucose sensors, an essential component of open- and closed-loop therapeutic systems for type 1 diabetes mellitus (T1DM). The goal of this work is to develop a model of plasma-to-ISF glucose kinetics from multitracer plasma and interstitium data, obtained by microdialysis, in healthy and T1DM subjects, under fasting conditions. Materials and Methods: A specific experimental design, combining administration of multiple tracers with the microdialysis technique, was used to simultaneously frequently collect plasma and ISF data. Linear time-invariant compartmental modeling was used to describe glucose kinetics from the tracer data because the system is in steady state. Results: A two-compartment model was shown accurate and was identified from both plasma and ISF data. An "equilibration time" between plasma and ISF of 9.1 and 11.0min (median) in healthy and T1DM subjects, respectively, was calculated. Conclusions: We have demonstrated that, in steady-state condition, the glucose plasma-to-ISF kinetics can be modeled with a linear two-compartment model and that the "equilibration time" between the two compartments can be estimated with precision. Future studies will assess plasma-to-interstitium glucose kinetics during glucose and insulin perturbations in both healthy and T1DM subjects.

Original languageEnglish (US)
Pages (from-to)825-831
Number of pages7
JournalDiabetes Technology and Therapeutics
Volume17
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Microdialysis
Extracellular Fluid
Glucose
Type 1 Diabetes Mellitus
Information Systems
Fasting
Research Design
Insulin

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology

Cite this

Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data. / Schiavon, Michele; Dalla Man, Chiara; Dube, Simmi; Slama, Michael; Kudva, Yogish C; Peyser, Thomas; Basu, Ananda; Basu, Rita; Cobelli, Claudio.

In: Diabetes Technology and Therapeutics, Vol. 17, No. 11, 01.11.2015, p. 825-831.

Research output: Contribution to journalArticle

Schiavon, M, Dalla Man, C, Dube, S, Slama, M, Kudva, YC, Peyser, T, Basu, A, Basu, R & Cobelli, C 2015, 'Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data', Diabetes Technology and Therapeutics, vol. 17, no. 11, pp. 825-831. https://doi.org/10.1089/dia.2015.0119
Schiavon, Michele ; Dalla Man, Chiara ; Dube, Simmi ; Slama, Michael ; Kudva, Yogish C ; Peyser, Thomas ; Basu, Ananda ; Basu, Rita ; Cobelli, Claudio. / Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data. In: Diabetes Technology and Therapeutics. 2015 ; Vol. 17, No. 11. pp. 825-831.
@article{b56f4e3b5a8f4a63a8df9c881f076bfb,
title = "Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data",
abstract = "Background: Quantitative assessment of the dynamic relationship between plasma and interstitial fluid (ISF) glucose and the estimation of the plasma-to-ISF delay are of major importance to determine the accuracy of subcutaneous glucose sensors, an essential component of open- and closed-loop therapeutic systems for type 1 diabetes mellitus (T1DM). The goal of this work is to develop a model of plasma-to-ISF glucose kinetics from multitracer plasma and interstitium data, obtained by microdialysis, in healthy and T1DM subjects, under fasting conditions. Materials and Methods: A specific experimental design, combining administration of multiple tracers with the microdialysis technique, was used to simultaneously frequently collect plasma and ISF data. Linear time-invariant compartmental modeling was used to describe glucose kinetics from the tracer data because the system is in steady state. Results: A two-compartment model was shown accurate and was identified from both plasma and ISF data. An {"}equilibration time{"} between plasma and ISF of 9.1 and 11.0min (median) in healthy and T1DM subjects, respectively, was calculated. Conclusions: We have demonstrated that, in steady-state condition, the glucose plasma-to-ISF kinetics can be modeled with a linear two-compartment model and that the {"}equilibration time{"} between the two compartments can be estimated with precision. Future studies will assess plasma-to-interstitium glucose kinetics during glucose and insulin perturbations in both healthy and T1DM subjects.",
author = "Michele Schiavon and {Dalla Man}, Chiara and Simmi Dube and Michael Slama and Kudva, {Yogish C} and Thomas Peyser and Ananda Basu and Rita Basu and Claudio Cobelli",
year = "2015",
month = "11",
day = "1",
doi = "10.1089/dia.2015.0119",
language = "English (US)",
volume = "17",
pages = "825--831",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data

AU - Schiavon, Michele

AU - Dalla Man, Chiara

AU - Dube, Simmi

AU - Slama, Michael

AU - Kudva, Yogish C

AU - Peyser, Thomas

AU - Basu, Ananda

AU - Basu, Rita

AU - Cobelli, Claudio

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Background: Quantitative assessment of the dynamic relationship between plasma and interstitial fluid (ISF) glucose and the estimation of the plasma-to-ISF delay are of major importance to determine the accuracy of subcutaneous glucose sensors, an essential component of open- and closed-loop therapeutic systems for type 1 diabetes mellitus (T1DM). The goal of this work is to develop a model of plasma-to-ISF glucose kinetics from multitracer plasma and interstitium data, obtained by microdialysis, in healthy and T1DM subjects, under fasting conditions. Materials and Methods: A specific experimental design, combining administration of multiple tracers with the microdialysis technique, was used to simultaneously frequently collect plasma and ISF data. Linear time-invariant compartmental modeling was used to describe glucose kinetics from the tracer data because the system is in steady state. Results: A two-compartment model was shown accurate and was identified from both plasma and ISF data. An "equilibration time" between plasma and ISF of 9.1 and 11.0min (median) in healthy and T1DM subjects, respectively, was calculated. Conclusions: We have demonstrated that, in steady-state condition, the glucose plasma-to-ISF kinetics can be modeled with a linear two-compartment model and that the "equilibration time" between the two compartments can be estimated with precision. Future studies will assess plasma-to-interstitium glucose kinetics during glucose and insulin perturbations in both healthy and T1DM subjects.

AB - Background: Quantitative assessment of the dynamic relationship between plasma and interstitial fluid (ISF) glucose and the estimation of the plasma-to-ISF delay are of major importance to determine the accuracy of subcutaneous glucose sensors, an essential component of open- and closed-loop therapeutic systems for type 1 diabetes mellitus (T1DM). The goal of this work is to develop a model of plasma-to-ISF glucose kinetics from multitracer plasma and interstitium data, obtained by microdialysis, in healthy and T1DM subjects, under fasting conditions. Materials and Methods: A specific experimental design, combining administration of multiple tracers with the microdialysis technique, was used to simultaneously frequently collect plasma and ISF data. Linear time-invariant compartmental modeling was used to describe glucose kinetics from the tracer data because the system is in steady state. Results: A two-compartment model was shown accurate and was identified from both plasma and ISF data. An "equilibration time" between plasma and ISF of 9.1 and 11.0min (median) in healthy and T1DM subjects, respectively, was calculated. Conclusions: We have demonstrated that, in steady-state condition, the glucose plasma-to-ISF kinetics can be modeled with a linear two-compartment model and that the "equilibration time" between the two compartments can be estimated with precision. Future studies will assess plasma-to-interstitium glucose kinetics during glucose and insulin perturbations in both healthy and T1DM subjects.

UR - http://www.scopus.com/inward/record.url?scp=84946404641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946404641&partnerID=8YFLogxK

U2 - 10.1089/dia.2015.0119

DO - 10.1089/dia.2015.0119

M3 - Article

C2 - 26313215

AN - SCOPUS:84946404641

VL - 17

SP - 825

EP - 831

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 11

ER -